Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX1 | P51575 | 1/20 | 0.40 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.40 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.40 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.40 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.40 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | PHGDH | O43175 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.37 |
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | PLG | P00747 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2612416 | 0.79 | P2RX1 (0.35) | P2RX1P2RX3P2RX4P2RX7CACNA1G | |
| SCHEMBL496708 | 0.77 | EGFR (0.38) | KMT2AMEN1ALDH1A1HPGDIDO1 | |
| SCHEMBL3859755 | 0.76 | RXFP1 (0.49) | P2RX1P2RX3P2RX4P2RX7CACNA1G | |
| SCHEMBL2608497 | 0.75 | RXFP1 (0.35) | P2RX1P2RX3P2RX4P2RX7CACNA1G | |
| SCHEMBL2870534 | 0.73 | CACNA1G (0.48) | CACNA1GCACNA1HCACNA1IRXFP1TSHR | |
| SCHEMBL2873764 | 0.72 | HDAC4 (0.60) | P2RX1P2RX3P2RX4P2RX7CACNA1G | |
| SCHEMBL1868600 | 0.71 | RXFP1 (0.49) | P2RX1P2RX3P2RX4P2RX7CACNA1G | |
| SCHEMBL10028542 | 0.70 | ALDH1A1 (0.47) | P2RX1P2RX3P2RX4P2RX7RXFP1 | |
| SCHEMBL10028496 | 0.69 | ALDH1A1 (0.50) | P2RX1P2RX3P2RX4P2RX7RXFP1 | |
| SCHEMBL31310490 | 0.69 | RXFP1 (0.63) | P2RX1P2RX3P2RX4P2RX7RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2027453-B1 | NONSEPARATION ASSAY METHODS | BECKMAN COULTER INC (US) | 2017-03-15 | — | — | EP | disclosed |
| EP-2021778-B1 | NONSEPARATION ASSAY METHODS | BECKMAN COULTER INC (US) | 2017-03-15 | — | — | EP | disclosed |
| US-8389298-B2 | Methods using novel chemiluminescent labels | LUMIGEN, INC. (US) | 2013-03-05 | — | — | US | disclosed |
| US-8389298-B2 | Methods using novel chemiluminescent labels | LUMIGEN, INC. (US) | 2013-03-05 | — | — | US | disclosed |
| US-8377647-B2 | Nonseparation assay methods | BECKMAN COULTER, INC. (US) | 2013-02-19 | — | — | US | disclosed |
| US-8377647-B2 | Nonseparation assay methods | BECKMAN COULTER, INC. (US) | 2013-02-19 | — | — | US | disclosed |
| US-20120094313-A1 | Nonseparation Assay Methods | BECKMAN COULTER, INC. (US) | 2012-04-19 | — | — | US | disclosed |
| US-20120094313-A1 | Nonseparation Assay Methods | BECKMAN COULTER, INC. (US) | 2012-04-19 | — | — | US | disclosed |
| US-8124362-B2 | Nonseparation assay methods | BECKMAN COULTER, INC. (US) | 2012-02-28 | — | — | US | disclosed |
| US-8124362-B2 | Nonseparation assay methods | BECKMAN COULTER, INC. (US) | 2012-02-28 | — | — | US | disclosed |
| US-7732153-B2 | Nonseparation assay methods | BECKMAN COULTER, INC. (US) | 2010-06-08 | — | — | US | disclosed |
| US-7732153-B2 | Nonseparation assay methods | BECKMAN COULTER, INC. (US) | 2010-06-08 | — | — | US | disclosed |
| US-7682839-B2 | Methods using novel chemiluminescent labels | LUMIGEN, INC. (US) | 2010-03-23 | — | — | US | disclosed |
| US-7682839-B2 | Methods using novel chemiluminescent labels | LUMIGEN, INC. (US) | 2010-03-23 | — | — | US | disclosed |
| US-20070264664-A1 | Nonseparation assay methods | NEXGEN DIAGNOSTICS LLC | 2007-11-15 | — | — | US | disclosed |
| US-20070264665-A1 | Nonseparation assay methods | BECKMAN COULTER, INC. | 2007-11-15 | — | — | US | disclosed |
| US-20070264665-A1 | Nonseparation assay methods | BECKMAN COULTER, INC. | 2007-11-15 | — | — | US | disclosed |
| US-20070264664-A1 | Nonseparation assay methods | NEXGEN DIAGNOSTICS LLC | 2007-11-15 | — | — | US | disclosed |
| US-20070172878-A1 | Methods using novel chemiluminescent labels | LUMIGEN, INC. | 2007-07-26 | — | — | US | disclosed |
| US-20070172878-A1 | Methods using novel chemiluminescent labels | LUMIGEN, INC. | 2007-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070172878-A1 | Methods using novel chemiluminescent labels | HLCS, LANCL1, ACR | P2RX1 4024/4885P2RX3 3825/4885P2RX4 3940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.